Senate bill weighs on Allergan, Medicis
November 19, 2009 at 10:39 AM EST
Allergan and Medicis Pharmaceutical Corp. lead drug stocks lower in morning activity as shares of the dermatology-products makers fall on news that the health-care reform bill put forth by Senate Democrats would levy a 5% tax on elective cosmetic procedures.